140 related articles for article (PubMed ID: 34606825)
21. GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination.
Salas-Marco J; Bedwell DM
Mol Cell Biol; 2004 Sep; 24(17):7769-78. PubMed ID: 15314182
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death 4 protein (Pdcd4) and homeodomain-interacting protein kinase 2 (Hipk2) antagonistically control translation of Hipk2 mRNA.
Ohnheiser J; Ferlemann E; Haas A; Müller JP; Werwein E; Fehler O; Biyanee A; Klempnauer KH
Biochim Biophys Acta; 2015 Jul; 1853(7):1564-73. PubMed ID: 25820028
[TBL] [Abstract][Full Text] [Related]
23. Elongation factor eEF1B modulates functions of the release factors eRF1 and eRF3 and the efficiency of translation termination in yeast.
Valouev IA; Fominov GV; Sokolova EE; Smirnov VN; Ter-Avanesyan MD
BMC Mol Biol; 2009 Jun; 10():60. PubMed ID: 19545407
[TBL] [Abstract][Full Text] [Related]
24. Eukaryotic release factor 3 is required for multiple turnovers of peptide release catalysis by eukaryotic release factor 1.
Eyler DE; Wehner KA; Green R
J Biol Chem; 2013 Oct; 288(41):29530-8. PubMed ID: 23963452
[TBL] [Abstract][Full Text] [Related]
25. Ribosome-bound Pub1 modulates stop codon decoding during translation termination in yeast.
Urakov VN; Mitkevich OV; Safenkova IV; Ter-Avanesyan MD
FEBS J; 2017 Jun; 284(12):1914-1930. PubMed ID: 28467675
[TBL] [Abstract][Full Text] [Related]
26. Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway.
Hoshino S; Hosoda N; Araki Y; Kobayashi T; Uchida N; Funakoshi Y; Katada T
Biochemistry (Mosc); 1999 Dec; 64(12):1367-72. PubMed ID: 10648960
[TBL] [Abstract][Full Text] [Related]
27. Translation termination depends on the sequential ribosomal entry of eRF1 and eRF3.
Beißel C; Neumann B; Uhse S; Hampe I; Karki P; Krebber H
Nucleic Acids Res; 2019 May; 47(9):4798-4813. PubMed ID: 30873535
[TBL] [Abstract][Full Text] [Related]
28. Antizyme frameshifting as a functional probe of eukaryotic translational termination.
Karamysheva ZN; Karamyshev AL; Ito K; Yokogawa T; Nishikawa K; Nakamura Y; Matsufuji S
Nucleic Acids Res; 2003 Oct; 31(20):5949-56. PubMed ID: 14530443
[TBL] [Abstract][Full Text] [Related]
29. Programmed cell death 4 mechanism of action: The model to be updated?
Vikhreva PN; Kalinichenko SV; Korobko IV
Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
[TBL] [Abstract][Full Text] [Related]
30. Nsp1 of SARS-CoV-2 stimulates host translation termination.
Shuvalov A; Shuvalova E; Biziaev N; Sokolova E; Evmenov K; Pustogarov N; Arnautova A; Matrosova V; Egorova T; Alkalaeva E
RNA Biol; 2021 Nov; 18(sup2):804-817. PubMed ID: 34793288
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for translational inhibition by the tumour suppressor Pdcd4.
Loh PG; Yang HS; Walsh MA; Wang Q; Wang X; Cheng Z; Liu D; Song H
EMBO J; 2009 Feb; 28(3):274-85. PubMed ID: 19153607
[TBL] [Abstract][Full Text] [Related]
32. A genetic approach for analyzing the co-operative function of the tRNA mimicry complex, eRF1/eRF3, in translation termination on the ribosome.
Wada M; Ito K
Nucleic Acids Res; 2014 Jul; 42(12):7851-66. PubMed ID: 24914055
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA.
Janzen DM; Frolova L; Geballe AP
Mol Cell Biol; 2002 Dec; 22(24):8562-70. PubMed ID: 12446775
[TBL] [Abstract][Full Text] [Related]
34. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.
Yang HS; Jansen AP; Komar AA; Zheng X; Merrick WC; Costes S; Lockett SJ; Sonenberg N; Colburn NH
Mol Cell Biol; 2003 Jan; 23(1):26-37. PubMed ID: 12482958
[TBL] [Abstract][Full Text] [Related]
35. The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay.
Kobayashi T; Funakoshi Y; Hoshino S; Katada T
J Biol Chem; 2004 Oct; 279(44):45693-700. PubMed ID: 15337765
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
Wang Q; Zhu J; Wang YW; Dai Y; Wang YL; Wang C; Liu J; Baker A; Colburn NH; Yang HS
Oncogene; 2017 Nov; 36(45):6225-6234. PubMed ID: 28692058
[TBL] [Abstract][Full Text] [Related]
37. The effect of eukaryotic release factor depletion on translation termination in human cell lines.
Janzen DM; Geballe AP
Nucleic Acids Res; 2004; 32(15):4491-502. PubMed ID: 15326224
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of human release factor 1 alone has an antisuppressor effect in human cells.
Le Goff X; Philippe M; Jean-Jean O
Mol Cell Biol; 1997 Jun; 17(6):3164-72. PubMed ID: 9154815
[TBL] [Abstract][Full Text] [Related]
39. Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation.
Singh P; Wedeken L; Waters LC; Carr MD; Klempnauer KH
Oncogene; 2011 Dec; 30(49):4864-73. PubMed ID: 21643008
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.
Liwak U; Thakor N; Jordan LE; Roy R; Lewis SM; Pardo OE; Seckl M; Holcik M
Mol Cell Biol; 2012 May; 32(10):1818-29. PubMed ID: 22431522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
